Gotowa bibliografia na temat „Anticancer drugs”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Anticancer drugs”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Anticancer drugs"

1

D, Subba Reddy, Prasanthi G, Amruth Raj S, Hari Krishna T, Sowjanya K, and Shantha Kumari K. "EVALUATION OF ANTICANCER GENERIC DRUGS AND BRANDED DRUGS." Indian Research Journal of Pharmacy and Science 5, no. 1 (2018): 1378–91. http://dx.doi.org/10.21276/irjps.2018.5.1.16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Reese, David M. "Anticancer drugs." Nature 378, no. 6557 (1995): 532. http://dx.doi.org/10.1038/378532c0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Jorayev, Muhammadyusuf Abdurakhim ugli Juraev Mukhammadyusuf. "ANTICANCER DRUGS." INTERNATIONAL BULLETIN OF MEDICAL SCIENCES AND CLINICAL RESEARCH 3, no. 4 (2023): 114–17. https://doi.org/10.5281/zenodo.7854262.

Pełny tekst źródła
Streszczenie:
The article presents an overview of anticancer drugs for medical use currently registered in Uzbekistan and at the final stage of their development - clinical trials in accredited testing centers for subsequent registration. The generalized information was obtained from official sources - the State Register of Medicines of the Ministry of Health of Uzbekistan, the Electronic Rubricator of Clinical Recommendations and Clinical Guidelines and orders on the Standards of Medical Care prepared on their basis. The place and role of chemotherapeutic agents in the treatment of oncological patients and
Style APA, Harvard, Vancouver, ISO itp.
4

Kutty, Dr A. V. M. "Usefulness of Phytochemicals as Anticancer Drugs." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 16, no. 1 (2019): 1–2. http://dx.doi.org/10.58739/jcbs/v09i1.7.

Pełny tekst źródła
Streszczenie:
Cancer is a state of uncontrolled proliferation and dedifferentiation of cells in any tissues or organs of the body. The incidence of cancer is rising alarmingly and is one of the leading causes of morbidity and mortality globally. Normal cell division is precisely a planned biological process controlled by regulatory genes and specific metabolic pathways. Exposure of normally functioning cells to carcinogens leads to mutations in the genes causing loss of control of cell division and transform into cancerous. Over a period of time, these cancer cells acquire more mutations; invade to adjoinin
Style APA, Harvard, Vancouver, ISO itp.
5

Atkins, Joshua H., and Leland J. Gershell. "Selective anticancer drugs." Nature Reviews Drug Discovery 1, no. 7 (2002): 491–92. http://dx.doi.org/10.1038/nrd842.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Atkins, Joshua H., and Leland J. Gershell. "Selective anticancer drugs." Nature Reviews Cancer 2, no. 9 (2002): 645–46. http://dx.doi.org/10.1038/nrc900.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Bibby, M. C. "Combretastatin anticancer drugs." Drugs of the Future 27, no. 5 (2002): 475. http://dx.doi.org/10.1358/dof.2002.027.05.668645.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Meegan, Mary J., and Niamh M. O’Boyle. "Special Issue “Anticancer Drugs”." Pharmaceuticals 12, no. 3 (2019): 134. http://dx.doi.org/10.3390/ph12030134.

Pełny tekst źródła
Streszczenie:
The focus of this Special Issue of Pharmaceuticals is on the design, synthesis, and molecular mechanism of action of novel antitumor, drugs with a special emphasis on the relationship between the chemical structure and the biological activity of the molecules. This Special Issue also provides an understanding of the biologic and genotypic context in which targets are selected for oncology drug discovery, thus providing a rationalization for the biological activity of these drugs and guiding the design of more effective agents. In this Special Issue of Pharmaceuticals dedicated to anticancer dr
Style APA, Harvard, Vancouver, ISO itp.
9

Ciarimboli, Giuliano. "Anticancer Platinum Drugs Update." Biomolecules 11, no. 11 (2021): 1637. http://dx.doi.org/10.3390/biom11111637.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Zhang, Jason Y. "Apoptosis-based anticancer drugs." Nature Reviews Drug Discovery 1, no. 2 (2002): 101–2. http://dx.doi.org/10.1038/nrd742.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Anticancer drugs"

1

Apps, MIchael Garry. "Platinum anticancer drugs and drug delivery systems." Thesis, The University of Sydney, 2015. http://hdl.handle.net/2123/14409.

Pełny tekst źródła
Streszczenie:
In this thesis two different ways to improve platinum-based chemotherapy were investigated. The first was through the use of a new slow release clay-based drug delivery vehicle and the second through the design and synthesis of novel dinuclear platinum complexes. For the clay-based drug delivery research, the platinum anticancer complex [(1,10-phenanthroline)(1S,2S-diaminocyclohexane)platinum(II)] chloride, PHENSS, was loaded into montmorillonite (MMT) clay. The PHENSS was found to be incompletely burst released from the MMT. The MMT also had a negative effect on the in vitro cytotoxicity of P
Style APA, Harvard, Vancouver, ISO itp.
2

Kozlowska, Hanna. "Interaction of dexrazoxane with anticancer drugs." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0001/MQ32158.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Tao, Zhimin. "Analysis of cytotoxicity of anticancer drugs." Related electronic resource:, 2007. http://proquest.umi.com/pqdweb?did=1407688361&sid=4&Fmt=2&clientId=3739&RQT=309&VName=PQD.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Liu, Tong. "The synthesis of novel anticancer drugs." Thesis, University of Glasgow, 2003. http://theses.gla.ac.uk/4464/.

Pełny tekst źródła
Streszczenie:
Our studies on the synthesis and biological evaluation of novel anticancer drugs consist of three research areas; namely, synthesis of Mitogen Activated Protein (MAP) kinase inhibitors, Checkpoint (Chk1) inhibitors and nordihydroguaiaretic acid (NDGA) analogues. The first research area involved synthesis of MAP kinase inhibitors. MAP kinases are a family of serine I and threonine II kinases which can act together to generate a process of phosphorylation events within the cell signalling pathway leading eventually to cell division. The compounds made in this project were specifically designed t
Style APA, Harvard, Vancouver, ISO itp.
5

Song, Di. "Bladder tissue pharmacokinetics of anticancer drugs /." The Ohio State University, 1996. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487940308433249.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Ratcliffe, Andrew J. "Synthesis of non-mutagenic anticancer drugs." Thesis, University of Bath, 1987. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378598.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Pettersson, Hanna Ilse. "Quinolinequinones as anticancer agents." Thesis, University of Exeter, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249038.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Wang, Shining. "DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS." Diss., Temple University Libraries, 2008. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/2535.

Pełny tekst źródła
Streszczenie:
Pharmaceutics<br>Ph.D.<br>EGFR inhibitors, such as gefitinib, are examples of targeted anticancer drugs whose drug sensitivity is related to gene mutations that adds a pharmacogenetic [PG] dimension to any pharmacokinetic [PK] and pharmacodynamic [PD] analysis. The goal of this project was to characterize the PK/PD properties of gefitinib in tumors and then apply these results to design rational drug design regimens, and provide a foundation for future studies with EGFR inhibitors. Progressions of in vitro and in vivo studies were completed to understand the PK and PD behavior of gefitinib. In
Style APA, Harvard, Vancouver, ISO itp.
9

Leczkowska, Anna. "Non-covalent DNA-binding ruthenium anticancer drugs." Thesis, University of Birmingham, 2011. http://etheses.bham.ac.uk//id/eprint/1695/.

Pełny tekst źródła
Streszczenie:
The research work described in this thesis concerns metal-based anticancer drugs with an emphasis on non-covalent DNA-binding supramolecular assemblies. The project involves the preparation of a series of mono- and bi-metallic ruthenium complexes with a primary focus on fluorescent dinuclear triple-stranded helicates with different structural topographies. Emphasis is then directed towards an investigation of the DNA binding characteristics of these molecules and an evaluation of their anticancer properties in human cancer cell lines. Attention is brought to the significance that the cylinder-
Style APA, Harvard, Vancouver, ISO itp.
10

Yarema, Kevin J. (Kevin Jon). "Cellular responses to platinum-based anticancer drugs." Thesis, Massachusetts Institute of Technology, 1994. http://hdl.handle.net/1721.1/33495.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Anticancer drugs"

1

1938-, Pratt William B., and Pratt William B. 1938-, eds. The anticancer drugs. 2nd ed. Oxford University Press, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Garth, Powis, ed. Anticancer drugs: Reactive metabolism and drug interactions. Pergamon Press, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Avendaño, Carmen. Medicinal chemistry of anticancer drugs. Elsevier, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Convention, United States Pharmacopeial. Fact sheets on anticancer drugs. National Cancer Institute [distributor], 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Garth, Powis, and Hacker Miles P, eds. The Toxicity of anticancer drugs. Pergamon Press, 1991.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

National Cancer Institute (U.S.), ed. Fact sheets on anticancer drugs. National Cancer Institute, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

1964-, Spencer Peter, and Holt Walter, eds. Anticancer drugs: Design, delivery and pharmacology. Nova Science Publishers, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Saeidnia, Soodabeh. New Approaches to Natural Anticancer Drugs. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-14027-8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Hacker, Miles P., John S. Lazo, and Thomas R. Tritton, eds. Organ Directed Toxicities of Anticancer Drugs. Springer US, 1988. http://dx.doi.org/10.1007/978-1-4613-2023-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Hildebrand, Jerzy, ed. Neurological Adverse Reactions to Anticancer Drugs. Springer Berlin Heidelberg, 1990. http://dx.doi.org/10.1007/978-3-642-76142-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Anticancer drugs"

1

Schacter, Lee, Marcel Rozencweig, Claude Nicaise, Renzo Canetta, Susan Kelley, and Laurie Smaldone. "Anticancer Drugs." In Early Phase Drug Evaluation in Man. Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-10705-6_49.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Schwab, Matthias, Elke Schaeffeler, and Hiltrud Brauch. "Anticancer Drugs." In Metabolism of Drugs and Other Xenobiotics. Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527630905.ch13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Isnard-Bagnis, Corinne, Vincent Launay-Vacher, Svetlana Karie, and Gilbert Deray. "Anticancer drugs." In Clinical Nephrotoxins. Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-84843-3_22.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Zhao, Le, Zengyi Shao, and Jacqueline V. Shanks. "Anticancer Drugs." In Industrial Biotechnology. Wiley-VCH Verlag GmbH & Co. KGaA, 2016. http://dx.doi.org/10.1002/9783527807833.ch8.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Ganguly, A. K., and Sesha Sridevi Alluri. "Anticancer Drugs." In Medicinal Chemistry. CRC Press, 2021. http://dx.doi.org/10.1201/9781003182573-4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Isnard-Bagnis, Corinne, and Gilbert Deray. "Anticancer drugs." In Clinical Nephrotoxins. Springer Netherlands, 2003. http://dx.doi.org/10.1007/1-4020-2586-6_18.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Cateni, Francesca, and Marina Zacchigna. "PEG–Anticancer Drugs." In Macromolecular Anticancer Therapeutics. Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-0507-9_6.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Kim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Immunotherapeutic Anticancer Drugs and Other Miscellaneous Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Kim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Alkylating Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Kim, Kyu-Won, Jae Kyung Roh, Hee-Jun Wee, and Chan Kim. "Antimetabolic Anticancer Drugs." In Cancer Drug Discovery. Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-024-0844-7_5.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Anticancer drugs"

1

Shiranirad, Saba, and Zeynab Barzegar. "Predictive Modeling of Drug Release from Liposomal Nano-Anticancer Drugs Using Advanced Machine Learning Techniques and TreeSHAP for Interpretability." In 2025 Eighth International Women in Data Science Conference at Prince Sultan University (WiDS PSU). IEEE, 2025. https://doi.org/10.1109/wids-psu64963.2025.00052.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Ma, Liang, Jeremy Barker, Changchun Zhou, Biaoyang Lin, and Wei Li. "A Perfused Two-Chamber System for Anticancer Drug Screening." In ASME 2010 International Manufacturing Science and Engineering Conference. ASMEDC, 2010. http://dx.doi.org/10.1115/msec2010-34326.

Pełny tekst źródła
Streszczenie:
A cell culture microfluidic device has been developed to test the cytotoxicity of anticancer drugs while reproducing multi-organ interactions in vitro. Cells were cultured in separate chambers representing the liver and tumor. The two chambers were connected through a channel to mimick the blood flow. Glioblastoma (GBM) cancer cells (M059K) and hepatoma cells (HepG2) were cultured in the tumor and the liver chambers, respectively. The cytotoxic effect of cancer treatment drug Temolozomide (TMZ) was tested using this two chamber system. The experimental results showed that with the liver cells,
Style APA, Harvard, Vancouver, ISO itp.
3

Schiestl, Robert H., Michael Davoren, and Yelena Rivina. "Abstract 1793: Novel radiation mitigators and anticancer drugs." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1793.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Settleman, Jeffrey E. "Abstract CN06-04: Reversible tolerance to anticancer drugs." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-cn06-04.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Schiestl, Robert H., Yelena Rivina, and Michael Davoren. "Abstract 3729: Novel radiation mitigators and anticancer drugs." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3729.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Zhukovets, T. A., M. А. Khancheuski, I. V. Koktysh, E. I. Kvasyuk, and A. G. Sysa. "ANTIOXIDANT EFFECTS OF EMOXYPINE AS ADJUVANT OF ANTI-CANCER DRUGS." In SAKHAROV READINGS 2021: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2021. http://dx.doi.org/10.46646/sakh-2021-2-52-55.

Pełny tekst źródła
Streszczenie:
Antioxidants are known to minimize oxidative stress by interacting with free radicals produced as a result of cell aerobic reactions. Oxidative stress has long been linked to many diseases, especially tumours. Therefore, antioxidants play a crucial role in the prevention or management of free radical-related diseases. However, most of these antioxidants have anticancer effects only if taken in large doses. Therefore, the combined use of antioxidants with chemotherapeutic agents is an attractive strategy to combat various tumours. This article focuses on the antioxidant effect of emoxypine. The
Style APA, Harvard, Vancouver, ISO itp.
7

Cao, Tingying, Xiangdong Gao, and Yueqing Gu. "Biodegradable polylactide microspheres containing anticancer drugs used as injectable drug delivery system." In 2007 IEEE/ICME International Conference on Complex Medical Engineering. IEEE, 2007. http://dx.doi.org/10.1109/iccme.2007.4381726.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

J., Alex Mathew, and Nixon Raj N. "Insilico Docking Studies on Anticancer Drugs for Breast Cancer." In 2009 International Association of Computer Science and Information Technology - Spring Conference. IEEE, 2009. http://dx.doi.org/10.1109/iacsit-sc.2009.12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Shrestha, Gajendra, Michael Xiao, Richard Robison, Larry L. St Clair, and Kim O'Neill. "Abstract 3220: Lichen derived polyphenols as potential anticancer drugs." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3220.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Ribeiro, Tatiane. "23 Evidence-based medicine challenges in new anticancer drugs." In EBM Live Abstracts, July 2019, Oxford, UK. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/bmjebm-2019-ebmlive.104.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Anticancer drugs"

1

Howard, David, Peter Bach, Ernst Berndt, and Rena Conti. Pricing in the Market for Anticancer Drugs. National Bureau of Economic Research, 2015. http://dx.doi.org/10.3386/w20867.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Zhang, Jian-Ting. Molecular Study of Interactions between P-Glycoprotein and Anticancer Drugs. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300162.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Inoue, Takashi, and Mamoru Narukawa. Anti-tumor efficacy of anti-PD-1/PD-L1 antibodies in combination with other anticancer drugs in solid tumors: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0004.

Pełny tekst źródła
Streszczenie:
Review question / Objective: The aim of this systematic review is to compare the combination of PD-1/PD-L1 inhibitors plus other anticancer drugs and monotherapies of PD-1/PD-L1 inhibitors in terms of antitumor efficacy in the solid tumors to better inform clinical practice. To this end, the proposed systematic review will address the following question: Which is the best choice to enhance response rate in subjects with solid tumors, PD-1/PD-L1 inhibitors plus cytotoxic agents or PD-1/PD-L1 inhibitors plus other targeted anticancer drugs? Condition being studied: Cancer is the leading cause of
Style APA, Harvard, Vancouver, ISO itp.
4

Biswas, Kaustav, and Samuel J. Danishefsky. Synthesis of Epothilone Analogs: Toward the Development of Potent Anticancer Drugs. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada409475.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Feltmate, Colleen. Application of Nanotechnology in the Targeted Release of Anticancer Drugs in Ovarian Cancer Treatment. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada486569.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Feltmate, Colleen. Application of Nanotechnology in the Targeted Release of Anticancer Drugs in Ovarian Cancer Treatment. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada481424.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Beerman, Terry A. Discovery of DNA Binding Anticancer Drugs That Target Oncogenic Transcription Factors Associated With Human Breast Cancer. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada403322.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Venedicto, Melissa, and Cheng-Yu Lai. Facilitated Release of Doxorubicin from Biodegradable Mesoporous Silica Nanoparticles. Florida International University, 2021. http://dx.doi.org/10.25148/mmeurs.009774.

Pełny tekst źródła
Streszczenie:
Cervical cancer is one of the most common causes of cancer death for women in the United States. The current treatment with chemotherapy drugs has significant side effects and may cause harm to healthy cells rather than cancer cells. In order to combat the potential side effects, nanoparticles composed of mesoporous silica were created to house the chemotherapy drug doxorubicin (DOX). The silica network contains the drug, and a pH study was conducted to determine the conditions for the nanoparticle to disperse the drug. The introduction of disulfide bonds within the nanoparticle created a fram
Style APA, Harvard, Vancouver, ISO itp.
9

Macedo, Luciana, and Linda Malkas. The Human Breast Cancer DNA Synthesome Can Serve as a Novel In Vitro Model System for Studying the Mechanism of Action of Anticancer Drugs. Defense Technical Information Center, 2000. http://dx.doi.org/10.21236/ada393926.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Jiang, Haiyan. The Human Breast Cancer Cell DNA Synthesome Can Serve as a Novel in Vitro Model System for Studying the Mechanism of Action of Anticancer Drugs. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada384124.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!